Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of hemodynamically significant patent ductus arteriosus in preterm neonates

This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: Primary objective To determine the diagnostic accuracy of the cardiac biomarkers BNP and NT-proBNP for diagnosis of hemodynamically significant patent ductus arteriosus (hsPDA) in preterm neonate